Friday, March 30, 2012

LIF will produce Sildenafil


LIF is making research and development of Sildenafil syrup and tablets.
Syldenafil syrup is an orphan medicine used to treat Pulmonary Arterial Hypertension (PAH)* of the newborn. This is developed with the Rosario’s National University, School of Sciences Biochemical and Pharmaceutical.
On the other hand LIF is working on the development of Sildenafil tablets used to treat erectile dysfunction.

* PAH is a rare disease with an incidence of about 2-3 per million per year and a prevalence of about 15 per million. Adult females are almost three times as likely to present with PAH as adult males. The presentation of IPAH within children is more evenly split along gender lines. (N. Rudarakanchana, R C Trembath, N. W. Morrel. New insights into the pathogenesis and treatment of primary pulmonary hypertension)

Tuesday, February 21, 2012

LIF will deliver antibiotics to Misiones

On January 2012, LIF participated in the latest public tender announced by the Health Ministry of Misiones to buy different medicines.
The better tender price for Cefalexin 250 mg Powder for Oral Suspension; Cefalexin 500 mg and Amoxicillin 500 mg tablets was made by LIF.
On this occasion, LIF will deliver 30.000 bottles of Cefalexin 250 mg Powder for Oral Suspension; 420.000 tablets of Cefalexin 500 mg and 420.000 tablets of Amoxicillin 500 mg.




Nationwide
LIF produces mainly 38 drugs for primary healthcare in Santa Fe.
From 2008, LIF provided also different medicines to the National Health Ministry through the REMEDIAR program.
Medicines as: Cefalexin 250 mg Powder for Oral Suspension; Cefalexin 500 mg; Amoxicillin 500 mg; Paracetamol 500 mg y Glibenclamida 5 mg (these last four products were tablets) were delivered to each 7000 CAPS (Primary Health Centres) of the Remediar Program
On 2010, LIF delivered 100.000 Amoxicillin 500 mg tablets and 10.000 Amoxicillin 250 mg. powder for oral suspension for Río Negro’s Health Ministry (a province in Southern Argentina).
On October 2011, LIF delivered in time 70.000 tablets of Amoxicillin 500 mg when it participated in the latest public tender announced by the Health Secretary of Bahía Blanca to buy different medicines.

Friday, February 17, 2012

LIF delivered antibiotics to Bahía Blanca

On October 2011, LIF participated in the latest public tender announced by the Health Secretary of Bahía Blanca to buy different medicines.
The better tender price for Amoxicillin 500 mg tablets was made by LIF.
On this occasion, LIF delivered in time 70.000 tablets of Amoxicillin 500 mg for Bahía Blanca.

Nationwide
LIF produces mainly 38 drugs for primary healthcare in Santa Fe.
From 2008, LIF provided also different medicines to the National Health Ministry through the REMEDIAR program.
Medicines as: Cefalexin 250 mg Powder for Oral Suspension; Cefalexin 500 mg; Amoxicillin 500 mg; Paracetamol 500 mg y Glibenclamida 5 mg (these last four products were tablets) were delivered to each 7000 CAPS (Primary Health Centres) of the Remediar Program
On 2010, LIF delivered 100.000 Amoxicillin 500 mg tablets and 10.000 Amoxicillin 250 mg. powder for oral suspension for Río Negro’s Health Ministry (a province in Southern Argentina).

Friday, February 3, 2012

LIF PARTICIPATED IN A SEMINAR IN MISIONES

On October 13 and 14, the LIF SE’s Directors Carlos Arques, Daniel Salomón, the General Syndic Carlos Minatti and the General Manager Roberto Ganin, attended a seminar organized by the National Health Ministry through the Programa Nacional de Producción Pública de Medicamentos, Vacunas y Productos Médicos.
This meeting took place in Posadas, Misiones.
The members of the LIF talked about Medicine Management in the Public Production and then they gave information about LIF's growth in medicine production in the last four years.
After this informative talk, they participated in a workshop with all the audience.

LIF at the UNS in Bahía Blanca

On November 2nd, 2011, the LIF SE’s Directors Ing. Carlos Arques and Bioq. Diego Bruno, participated a conference organized by the students of Biología, Bioquímica and Farmacia of the Departamento de Bioquímica, Química y Farmacia. This meeting took place at the Universidad Nacional del Sur (UNS), Bahía Blanca.

The LIF’s Directors talked about State Medicine Production, they gave information about LIF of Santa Fe and they participated in a workshop with all students.

After conference, the LIF’s Directors met with the Rector of the UNS, Dr. Guillermo Héctor Crapiste; the Directors, Lic. Miguel Hugo Lliteras and Dra. Verónica Bucalá. They talked about the possibility of signing an agreement of “Collaboration and mutual assistance” with the Departamento de Ingeniería Química.

Thursday, November 17, 2011

LIF PARTICIPATED IN THE 44th NATIONAL MEETING of PHARMACEUTHICAL SCIENCES IN MEXICO


From October 23rd to October 26th, the LIF SE’s Director Guillermo Cleti, attended Annual Meeting organized by the Asociación Farmacéutica Mexicana, A.C. (AFMAC).
This meeting attracts over 700 assistant every year. This year, it took place at the Hotel Dorado Pacífico Ixtapa, Zihuatanejo, Guerrero, México.

The Director of the LIF participated in the forum called “Policies for medicines”. He talked about “medicine as social benefit” and “Medicine Management in the Public Production in Santa Fe”.
After this informative talk, he participated in a workshop with all the audience.

Pharm. Guillermo Cleti and Lic. Matilde Ruderman of Argentina, with AFMC's members: Vicente Hernandez Abad (President), Jorge Guevara (Executive Director) and Cynthia Espinosa Contreras (Director of Science and Technology)

Tuesday, November 15, 2011

LIF PARTICIPATED IN A SEMINAR IN MISIONES

On October 13 and 14, the LIF SE’s Directors Carlos Arques, Daniel Salomón, the General Syndic Carlos Minatti and the General Manager Roberto Ganin, attended a seminar organized by the National Health Ministry through the Programa Nacional de Producción Pública de Medicamentos Vacunas y Productos Médicos.
This meeting took place in Posadas, Misiones.

The members of the LIF talked about Medicine Management in the Public Production and then they gave information about LIF's growth in medicine production in the last four years.
After this informative talk, they participated in a workshop with all the audience.